Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance

BACKGROUND: This all-case post-marketing surveillance (PMS) evaluated the real-world safety and effectiveness of nivolumab monotherapy in Japanese patients with un-resectable or metastatic renal cell carcinoma (RCC). METHODS: This multicenter, open-label, non-interventional, observational PMS study...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Hirotsugu, Tomita, Yoshihiko, Nonomura, Norio, Yoshizaki, Kenji, Nakao, Takafumi, Shinohara, Nobuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119881/
https://www.ncbi.nlm.nih.gov/pubmed/35441907
http://dx.doi.org/10.1007/s10147-022-02155-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119881/
https://www.ncbi.nlm.nih.gov/pubmed/35441907
http://dx.doi.org/10.1007/s10147-022-02155-3

Ejemplares similares